Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Philip Berry.
Newcastle Authors
Title
Year
Full text
Dr Catherine Gowland
Philip Berry
Julie Errington
Professor Gareth Veal
Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study
2021
Mankaran Singh
Dr Helen Blair
Philip Berry
Professor Olaf Heidenreich
Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS
2020
Dr Karen Barker
Philip Berry
Professor Gareth Veal
Dr John Anderson
In vivo
Modelling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis
2019
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al.
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)
2019
Dr Rosanna Jackson
Philip Berry
Julie Errington
Professor Julie Irving
Professor Gareth Veal
et al.
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia - a report from the UKALL 2011 trial
2019
Professor Gareth Veal
Philip Berry
Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste
2019
Dr Lindi Chen
Philip Berry
Dr Jennifer Bonner
Calum Kirk
Dr Katrina Wood
et al.
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma
2019
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al.
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
2019
Philip Berry
Cancer-related health behaviours of young people not in education, employment or training ('NEET'): a cross-sectional study
2018
Monique Zangarini
Philip Berry
Professor Gareth Veal
Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts
2018
Dr Lynsey McKenzie
Hasan Issa
Sandeep Potluri
Dr Helen Blair
Asmida Isa
et al.
The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
2018
Dr Sally Coulthard
Sarah McGarrity
Dr Kiran Sahota
Philip Berry
Dr Chris Redfern
et al.
Three Faces of Mercaptopurine Cytotoxicity in vitro: Methylation, Nucleotide Homeostasis and Deoxythioguanosine in DNA
2018
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Chris Redfern
Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone
2017
Monique Zangarini
Philip Berry
Julieann Sludden
Professor Gareth Veal
Development and validation of a LC-MS/MS method for the quantification of the checkpoint kinase 1 inhibitor SRA737 in human plasma
2017
Monique Zangarini
Professor Neil Rajan
Dr Marina Danilenko
Philip Berry
Professor Gareth Veal
et al.
Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors
2017
Dr Lindi Chen
Philip Berry
Dr Jennifer Bonner
Dr Katrina Wood
Professor Gareth Veal
et al.
In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in
TP53
wild-type orthotopic models of neuroblastoma
2017
Professor Gareth Veal
Carine Boue
Charlotte Lecour
Annette Otto
Maryam Rastegari
et al.
Investigating the roles and training of paediatric research nurses working across Europe: a questionnaire-based survey
2017
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Chris Redfern
A Novel Assay for The Direct Detection of Deoxythioguanosine (DTG) in DNA from Patients On Azathioprine Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)
2016
Philip Berry
Dr Anthony Oxley
Professor Georg Lietz
A Retinol Isotope Dilution Equation Predicts Both Group and Individual Total Body Vitamin A Stores in Adults Based on Data from an Early Postdosing Blood Sample
2016
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Abdul-Haq Ansari
Dr Chris Redfern
et al.
Deoxythioguanosine (DTG) in DNA as a Pharmacological Endpoint of Thiopurine Treatment in Inflammatory Bowel Disease Patients
2016
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Chris Redfern
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients
2016
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Chris Redfern
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients
2016
Dr Anthony Oxley
Philip Berry
Professor Georg Lietz
Plasma Retinol Kinetics and β-Carotene Bioefficacy Are Quantified by Model-Based Compartmental Analysis in Healthy Young Adults with Low Vitamin A Stores
2016
Professor Georg Lietz
Dr Anthony Oxley
Philip Berry
Professor John Hesketh
Dr Franck Tourniaire
et al.
β-carotene (BC) bioconversion is similar in men and women
2015
Dr Anthony Oxley
Philip Berry
Gordon Taylor
Dr Joe Cowell
Dr Michael Hall
et al.
An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion and vitamin A status in humans
2014
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Chris Redfern
Direct Detection of Thiopurine Metabolites in Erythrocytes and Leukocytes Using a Novel LCMS/MS Method to Interrogate Drug Response and
in vivo
Metabolism
2014
Emily Mould
Philip Berry
Dr David Jamieson
Dr Chris Hill
Dr Celine Cano
et al.
Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity
2014
Dr Hyun Jin Park
Professor Georg Lietz
Dr Anthony Oxley
Professor Alan Boddy
Philip Berry
et al.
Simplified approaches for estimating vitamin A stores and β-carotene bioconversion in humans
2014
Dr Lindi Chen
Dr Yan Zhao
Dr Gail Halliday
Philip Berry
Professor Herbie Newell
et al.
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma
2014
Emily Mould
Stephanie Burnell
Philip Berry
Professor Herbie Newell
Dr Elaine Willmore
et al.
The novel and contrasting roles of ATM and DNA-PK in the response of cells to microtubule-targeting anticancer agents
2014
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Patterson
et al.
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
2014
Dr Anthony Oxley
Philip Berry
Professor John Hesketh
Professor Alan Boddy
Professor Georg Lietz
et al.
Gender differences in retinol metabolism are independent of β-carotene bioconversion
2013
Emily Mould
Philip Berry
Dr David Jamieson
Dr Chris Hill
Niu Tan
et al.
The DNA-PK inhibitor, NU7441, sensitises cancer cells to microtubule-targeting agents and modulates vincristine efflux in multidrug resistant cells
2013
Professor Colin Ingram
Philip Berry
Dr John Ingram
Differential expression of GABA-A receptor sub-unit and glutamic acid decarboxylase (GAD) mRNAs in the forebrain of Fischer and Lewis rats
2005